The ZYVAXIS brand, founded in 2013 (Belgium), from 248 sister brands and 17477 competing brands. ZYVAXIS is owned by GLAXOSMITHKLINE, listed on the stock exchange of London The International Securities Identification Number (ISIN) of GLAXOSMITHKLINE is GB0009252882. ZYVAXIS belongs to the Drug Manufacturers business sector.

ZYVAXIS is a brand of GLAXOSMITHKLINE (GSK/L) Share price

International deposit : 2013 Business sector Drug Manufacturers

Share price and profitability of the share GLAXOSMITHKLINE (ZYVAXIS)

Buy GLAXOSMITHKLINE share with
(0% commission and fractional shares)
Your capital is subject to risk. Other fees apply. For more information, visit etoro.com/trading/fees.

Investment simulator :

Amount invested GBX 1,654.50

Portfolio valuation
GLAXOSMITHKLINE (ZYVAXIS) over 5 years* GBX 1,404.79

Stock market history GLAXOSMITHKLINE (ZYVAXIS)

*non inclusive of dividends, non inclusive of market orders
past performances do not prejudice future performances

Other brands
GLAXOSMITHKLINE

See more brands of GLAXOSMITHKLINE

Rival brands
ZYVAXIS

POINT BIOPHARMA
POINT BIOPHARMA
Icosavax
Icosavax
OGX
OGX
MAUI MOISTURE
MAUI MOISTURE
POLYSPORIN
POLYSPORIN
LACTAID
LACTAID
OTHER RIVAL BRANDS

Top Popularity Web

See the full ranking
Desirable brands > Pricing Power > 5 major sectors
Desirable brands > Pricing Power > 5 major sectors

Only companies with a strong brand or unique know-how benefit from this ability to set their prices without impacting demand and thus preserve their margins.

Read more
MORE NEWS